Literature DB >> 4880606

Growth of bacteriophage f2 in E. coli treated with rifampicin.

H P Fromageot, N D Zinder.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1968        PMID： 4880606      PMCID： PMC285921          DOI： 10.1073/pnas.61.1.184

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN： 0027-8424            Impact factor:   11.205


× No keyword cloud information.
  16 in total

1.  HOST-DEPENDENT MUTANTS OF THE BACTERIOPHAGE F2. IV. ON THE BIOSYNTHESIS OF A VIRAL RNA POLYMERASE.

Authors:  H F LODISH; S COOPER; N D ZINDER
Journal:  Virology       Date:  1964-09       Impact factor: 3.616

2.  DISC ELECTROPHORESIS. II. METHOD AND APPLICATION TO HUMAN SERUM PROTEINS.

Authors:  B J DAVIS
Journal:  Ann N Y Acad Sci       Date:  1964-12-28       Impact factor: 5.691

3.  THE REPLICATION OF BACTERIOPHAGE MS2. IV. RNA COMPONENTS SPECIFICALLY ASSOCIATED WITH INFECTION.

Authors:  R B KELLY; J L GOULD; R L SINSHEIMER
Journal:  J Mol Biol       Date:  1965-03       Impact factor: 5.469

4.  Replication of the RNA of Bacteriophage f2.

Authors:  H F Lodish; N D Zinder
Journal:  Science       Date:  1966-04-15       Impact factor: 47.728

5.  Differential synthesis of bacteriophage-specific proteins in MS2-infected Escherichia coli treated with actinomycin.

Authors:  M P Oeschger; D Nathans
Journal:  J Mol Biol       Date:  1966-12-28       Impact factor: 5.469

6.  Virus-specific proteins in Escherichia coli infected with some amber mutants of phage MS2.

Authors:  E Viñuela; I D Algranati; G Feix; D Garwes; C Weissmann; S Ochoa
Journal:  Biochim Biophys Acta       Date:  1968-02-26

7.  The specific inhibition of the DNA-directed RNA synthesis by rifamycin.

Authors:  G Hartmann; K O Honikel; F Knüsel; J Nüesch
Journal:  Biochim Biophys Acta       Date:  1967

8.  Synthesis of virus-specific proteins in Escherichia coli infected with the RNA bacteriophage MS2.

Authors:  E Viñuela; I D Algranati; S Ochoa
Journal:  Eur J Biochem       Date:  1967-03

9.  Rifampicin: a new orally active rifamycin.

Authors:  N Maggi; C R Pasqualucci; R Ballotta; P Sensi
Journal:  Chemotherapy       Date:  1966       Impact factor: 2.544

10.  Amber mutants and chain termination in vitro.

Authors:  R E Webster; D L Engelhardt; N D Zinder; W Konigsberg
Journal:  J Mol Biol       Date:  1967-10-14       Impact factor: 5.469
View more
  24 in total

1.  Discriminative effect of rifampin of RNA replication of various RNA bacteriophages.

Authors:  H Engelberg; I Brudo; M Israeli-Reches
Journal:  J Virol       Date:  1975-08       Impact factor: 5.103

Review 2.  Bacteriophage lysis: mechanism and regulation.

Authors:  R Young
Journal:  Microbiol Rev       Date:  1992-09

3.  Replication of RNA bacteriophages in the presence of rifamycin.

Authors:  V Bauman; P Pumpen; A Dishler; E J Gren
Journal:  J Virol       Date:  1978-12       Impact factor: 5.103

4.  Inhibition of induction of group A bacteriocins of Serratia marcescens by rifampin.

Authors:  W H Traub
Journal:  Experientia       Date:  1972-08-15

5.  Deductive analysis of a protein-synthesis mutant of Escherichia coli.

Authors:  D Patterson; D Gillespie
Journal:  Biochem Genet       Date:  1973-02       Impact factor: 1.890

6.  Use of miracil D to suppress bacterial ribonucleic acid and protein synthesis during bacteriophage MS2 infection.

Authors:  J H Cramer; R L Sinsheimer
Journal:  J Virol       Date:  1972-02       Impact factor: 5.103

Review 7.  Translation of the genome of a ribonucleic acid bacteriophage.

Authors:  M Kozak; D Nathans
Journal:  Bacteriol Rev       Date:  1972-03

8.  Intermediates of bacteriophage MS2 assembly in vivo.

Authors:  P H Bonner
Journal:  J Virol       Date:  1974-11       Impact factor: 5.103

9.  Messenger characteristics of nascent bacteriophage RNA.

Authors:  H D Robertson; H F Lodish
Journal:  Proc Natl Acad Sci U S A       Date:  1970-10       Impact factor: 11.205

10.  Inhibition of replication of ribonucleic acid bacteriophage f2 by superinfection with bacteriophage T4.

Authors:  E Goldman; H F Lodish
Journal:  J Virol       Date:  1971-10       Impact factor: 5.103
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.